Charles Schwab Trust CO Amgen Inc Transaction History

Charles Schwab Trust CO

$1.07 Billion
Q2 2024

A detailed history of Charles Schwab Trust CO transactions in Amgen Inc stock. As of the latest transaction made, Charles Schwab Trust CO holds 1,729 shares of AMGN stock, worth $574,806. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,729

Previous 1,424 21.42%

Holding current value

$574,806

Previous $404,000 33.66%

% of portfolio

0.05%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$262.75 - $319.31 $80,138 - $97,389	305 Added 21.42%	1,729 $540,000
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $5,108 - $6,166	-19 Reduced 1.32%	1,424 $404,000
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $21,865 - $27,145	-100 Reduced 6.48%	1,443 $387,000
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $28,399 - $36,085	-124 Reduced 7.44%	1,543 $0
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $29,179 - $32,909	-130 Reduced 7.23%	1,667 $376,000
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $29,992 - $33,376	130 Added 7.8%	1,797 $437,000
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $6,578 - $7,277	-30 Reduced 1.77%	1,667 $403,000
Q3 2021 Oct 08, 2021	SELL	$212.27 - $248.7 $1,910 - $2,238	-9 Reduced 0.53%	1,697 $361,000
Q2 2021 Aug 04, 2021	BUY	$233.58 - $259.14 $31,066 - $34,465	133 Added 8.46%	1,706 $416,000
Q1 2021 Apr 14, 2021	SELL	$221.91 - $258.6 $98,749 - $115,077	-445 Reduced 22.05%	1,573 $392,000
Q4 2020 Jan 14, 2021	BUY	$216.38 - $257.67 $9,520 - $11,337	44 Added 2.23%	2,018 $464,000
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $17,598 - $19,571	75 Added 3.95%	1,974 $502,000
Q1 2020 Apr 09, 2020	SELL	$182.24 - $241.7 $911 - $1,208	-5 Reduced 0.26%	1,899 $385,000
Q3 2019 Nov 15, 2019	BUY	$174.11 - $208.62 $331,505 - $397,212	1,904 New	1,904 $368,000

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Trust CO with notifications on news.

Account

Charles Schwab Trust CO Amgen Inc Transaction History